Validations: Dirty/Clean Equipment Hold-Time

Common DHT/CHT Gaps—and How to Close Them

Common DHT/CHT Gaps—and How to Close Them Common DHT/CHT Gaps—and How to Close Them The pharmaceutical industry constantly strives to improve its validation processes, especially regarding cleaning and hold-time studies. This guide provides a comprehensive overview of dirty hold-time (DHT) and clean hold-time (CHT) considerations, particularly for bulk and intermediate materials. It offers actionable steps to close common gaps observed…

Continue Reading Common DHT/CHT Gaps—and How to Close Them

Vendor Skids and Vessels: Incoming Qualification of Hold Claims

Vendor Skids and Vessels: Incoming Qualification of Hold Claims The effective management of equipment hold time is crucial in pharmaceuticals, with implications on product quality and compliance to cGMP regulations. This article serves as a detailed step-by-step tutorial for healthcare professionals focusing on vendor skids and vessels, specifically concerning the incoming qualification of hold claims related to dirty and clean…

Continue Reading Vendor Skids and Vessels: Incoming Qualification of Hold Claims

Hold-Time in Single-Use Equipment: Special Considerations

Hold-Time in Single-Use Equipment: Special Considerations Hold-Time in Single-Use Equipment: Special Considerations The use of single-use equipment in pharmaceuticals presents unique challenges when assessing hold-time specifications. Understanding the critical aspects of cleaning processes, equipment hold time, and regulatory requirements is vital for ensuring compliance with FDA, EMA, and MHRA standards. This guide provides a step-by-step approach for professionals engaged in…

Continue Reading Hold-Time in Single-Use Equipment: Special Considerations

CHT in Aseptic Fill/Finish: Sterility Hooks and Records

CHT in Aseptic Fill/Finish: Sterility Hooks and Records Aseptic fill/finish operations are critical to ensuring the safety and efficacy of pharmaceutical products. One of the essential aspects of these operations is conducting Comprehensive Hold-Time Studies (CHT) for both dirty and clean equipment, as well as bulk hold time assessments. This article will provide a detailed guide for pharmaceutical professionals on…

Continue Reading CHT in Aseptic Fill/Finish: Sterility Hooks and Records

Sampling Plans for Complex Trains: Pipes, Tanks, and Filters

Sampling Plans for Complex Trains: Pipes, Tanks, and Filters Sampling Plans for Complex Trains: Pipes, Tanks, and Filters The pharmaceutical industry operates under strict regulatory guidelines set by organizations such as the US FDA, EMA, and MHRA. One crucial aspect of compliance involves managing equipment hold times, particularly for complex systems like pipes, tanks, and filters. This guide provides a…

Continue Reading Sampling Plans for Complex Trains: Pipes, Tanks, and Filters

Designing Studies During Turnaround Constraints

Designing Studies During Turnaround Constraints Designing Studies During Turnaround Constraints In the highly regulated pharmaceutical industry, maintaining compliance with Good Manufacturing Practices (GMPs) is essential, particularly when conducting studies on equipment hold time, bulk holds, and cleaning validation. With stringent expectations from regulatory authorities such as the US FDA, EMA, MHRA, and guidance documents like Annex 15, competent pharmaceutical professionals…

Continue Reading Designing Studies During Turnaround Constraints

Failure Modes in Hold-Time: Deviations and CAPA

Failure Modes in Hold-Time: Deviations and CAPA Understanding Failure Modes in Hold-Time: Deviations and CAPA 1. Introduction to Equipment Hold Time The concept of hold time in pharmaceutical operations pertains to the duration that materials, equipment, and products can remain in a particular state without undergoing detrimental changes. Understanding equipment hold time is crucial for maintaining the integrity of products,…

Continue Reading Failure Modes in Hold-Time: Deviations and CAPA

Micro Recovery & Extraction Efficiency: Correction Factors

Micro Recovery & Extraction Efficiency: Correction Factors Micro Recovery & Extraction Efficiency: Correction Factors In the realm of pharmaceutical manufacturing, understanding the dynamics of cleaning processes, particularly as they relate to equipment hold time and recovery rates, is essential. Knowing how to assess and apply correction factors effectively can determine the safety and efficacy of pharmaceutical products. This article aims…

Continue Reading Micro Recovery & Extraction Efficiency: Correction Factors

Detergent Residues and Endotoxin: Dual-Risk Controls

Detergent Residues and Endotoxin: Dual-Risk Controls Detergent Residues and Endotoxin: Dual-Risk Controls In the pharmaceutical industry, maintaining a sterile environment is paramount to ensuring the quality of products and the safety of consumers. Regulatory agencies such as the FDA, EMA, and MHRA have established strict guidelines for cleaning processes, equipment hold times, and controls over potential contaminants. Among these contaminants…

Continue Reading Detergent Residues and Endotoxin: Dual-Risk Controls

Evidence Packs for DHT/CHT: What Reviewers Ask

Evidence Packs for DHT/CHT: What Reviewers Ask The validation of cleaning processes, particularly in the pharmaceutical industry, is paramount for ensuring product quality and patient safety. The determination of equipment hold time, especially for dirty cleanrooms (DHT) and clean cleanrooms (CHT), has become increasingly important in regulatory compliance. In this guide, we delve into the intricate details of hold-time studies,…

Continue Reading Evidence Packs for DHT/CHT: What Reviewers Ask